Feature BioLight dry eye subsidiary approaching CE Mark filing, U.S. pivotal trial By Len Zehrs DiagnosTear, the dry eye diagnostic subsidiary of BioLight Life Sciences (TASE:BOLT), hopes to file by the end of 2017 for CE Mark approval in Europe and begin a pivotal trial in the U.S. in mid-2018 with... November 28, 2017